伍俊妍,吴凯珊,郑志华
WU Junyan,WU Kaishan,ZHENG Zhihua

• 1:中山大学孙逸仙纪念医院
• 2:广东省药学会

摘要(Abstract)：

处方级联是指处方给患者一种药物,引起了不良事件体征和症状,为处理这些不良事件体征和症状,从而导致新的药物处方的情况。这个新的药物处方又可引起新的不良事件体征和症状,从而产生下一个处方级联。处方级联的概念在1995年被国外学者提出并得到认同且被广泛研究;而在国内,处方级联尚未得到关注及重视。处方级联危害患者健康,应被关注及研究。
A prescribing cascade occurs when a new drug was prescribed to "treat "an adverse reaction of another drug. The definition of prescribing cascade was raised by the foreign scholars in 1995 initially,and had been widespread to be recognized and researched. However,prescribing cascade had not given enough attention in China. Prescribing cascade is harmful for patients,and need to be recognized and researched in China.

关键词(KeyWords)： 处方级联;合理用药;处方精简
prescribing cascade;rational medication;deprescribing

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 伍俊妍,吴凯珊,郑志华
WU Junyan,WU Kaishan,ZHENG Zhihua

参考文献(References)：

• [1]Rochon P A,Gurwitz J H.Drug therapy[J].Lancet,1995,346(8966):32-36.
• [2]Kalisch L M,Caughey G E,Roughead E E,et al.The prescringcascade[J].Australian Prescriiber,2011,34(6):162-166.
• [3]Farrell B,Pottie K,Thompson W,et al.Deprescribing proton pump inhibitors[J].Canadian Family Physician,2017,63(5):354-364.
• [4]Ponte M L,Wachs L,Wachs A,et al.Prescribing cascade.A proposed new way to evaluate it[J].Medicina,2017,77(1):13.
• [5]Brodsky P T,Papale R M,Bignone I M.Farmacovigilanciahospitalaria en Buenos Aires[J].Medicina(B Aires),2014,74:84-85.
• [6]Rochon P A,Gurwitz J H.Optimisingdrug treatment for elderly people:the prescribing cascade[J].BMJ,1997,315(7115):1096-1099.
• [7]American Geriatrics Society.Updated Beers Criteria for potentially inappropriate medication use in older adults[J].J Am Geriatr Soc,2012,60(4):616-631.
• [8]Ponte M,Ragusa M,Serra H A.Enfoqueprácticopara la prevención dereaccionesadversasmedicamentosas y potencialesinteraccionesmedicamentosas[J].Prensa Med,2011,98:684-691.
• [9]Ponte M L,Ragusa M,Armenteros C,et al.Relevancia de la farmacovigilancia hospitalaria en la práctica médica actual[J].Medicina(B Aires),2013,73:35-38.
• [10]Nguyen P V,Spinelli C.Prescribing cascade in an elderly woman[J].Canadian pharmacists journal,2016,149(3):122.
• [11]Harpaz R,Du Mouchel W,Shah N H,et al.Noveldata-mining methodologies for adverse drug event discovery and analysis[J].ClinPharmacol Ther,2012,91(6):1010-1021.
• [12]Farrell B,Pottie K,Rojas-Fernandez C H,et al.Methodology for Developing Deprescribing Guidelines:Using Evidence and GRADE to Guide Recommendations for Deprescribing[J].PLo S One,2016,11(8):e0161248.
• [13]Rababa M,Alghassani A A,Kovach C R,et al.Proton pump inhibitors and the prescribing cascade[J].Journal of Gerontological Nursing,2016,42(4):23.
• [14]曾英彤,杨敏,伍俊妍,等.药学服务新模式——处方精简[J].今日药学,2017,27(6):390-393.
• [15]Scott I,Hilmer S N,Reeve E,et al.The process of deprescribing[J].JAMA,2015,175(5):827-834.